Monthly Communication Reports in:
July
2023
Other options for searching the Registry: 12-Month Lobbying Activity Search; Advanced Registry Search; Recent Registrations; and Recent Monthly Communication Reports.
The list below is sorted by communication date, beginning with the most recent.
Cystic Fibrosis Canada/Fibrose kystique Canada
Kelly
Grover,
President and Chief Executive Officer
(Organization)
-
Cystic Fibrosis Canada
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Susan Fitzpatrick,
Head, Canadian Drug Agency Transition Office
| Strategic Policy Branch
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2023-07-11
Posted date:
2023-08-02
Communication number:
266824-573758
View monthly communication report
